These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34029643)

  • 21. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
    Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
    Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.
    Habermehl D; Lindel K; Rieken S; Haase K; Goeppert B; Büchler MW; Schirmacher P; Welzel T; Debus J; Combs SE
    Strahlenther Onkol; 2012 Sep; 188(9):795-801. PubMed ID: 22526232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
    Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.
    Song C; Kim K; Chie EK; Kim JH; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):499-504. PubMed ID: 24074923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database.
    Zhu Y; Liu X; Lin Y; Tang L; Yi X; Xu H; Yuan Y; Chen Y
    Eur J Med Res; 2023 Sep; 28(1):310. PubMed ID: 37658421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer.
    Im JH; Park JS; Yoon DS; Lee DK; Kim JW; Lee IJ
    Sci Rep; 2019 Mar; 9(1):5061. PubMed ID: 30911043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
    Jang JY; Kim SW; Park DJ; Ahn YJ; Yoon YS; Choi MG; Suh KS; Lee KU; Park YH
    Ann Surg; 2005 Jan; 241(1):77-84. PubMed ID: 15621994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
    Shi XQ; Zhang JY; Tian H; Tang LN; Li AL
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):549-559. PubMed ID: 32633109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Kim J; Ahn S; Kim K; Cho MS; Kim KH; Lee RA; Nam EM
    Anticancer Res; 2018 Dec; 38(12):6881-6889. PubMed ID: 30504405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer.
    Lee HS; Lee SH; Roh YH; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
    Chemotherapy; 2016; 61(3):152-8. PubMed ID: 26788726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin.
    Han IW; Jang JY; Lee KB; Kang MJ; Kwon W; Park JW; Chang YR; Kim SW
    HPB (Oxford); 2014 Jun; 16(6):575-81. PubMed ID: 24308425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.
    Song S; Wu HG; Lee CG; Keum KC; Kim MS; Ahn YC; Oh D; Park HJ; Lee SW; Park G; Moon SH; Cho KH; Kim YS; Won Y; Oh YT; Kim WT; Jeong JU
    BMC Cancer; 2017 Aug; 17(1):598. PubMed ID: 28854890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy.
    Wang Y; Zhang J; Zhou M; Yang L; Wan J; Shen L; Liang L; Yao Y; Zhang H; Zhang Z
    Cancer Med; 2019 Apr; 8(4):1508-1520. PubMed ID: 30790459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
    Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
    Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.